![](/img/cover-not-exists.png)
Safety and tolerability of the poly(ADP-ribose) polymerase (PARP) inhibitor, olaparib (AZD2281) in combination with topotecan for the treatment of patients with advanced solid tumors: a phase I study
Jens Samol, Malcolm Ranson, Edwina Scott, Euan Macpherson, James Carmichael, Anne Thomas, James CassidyVolume:
30
Language:
english
Pages:
8
DOI:
10.1007/s10637-011-9682-9
Date:
August, 2012
File:
PDF, 215 KB
english, 2012